dc.contributor.author | Demirdag, C. | |
dc.contributor.author | Onal, Bülent | |
dc.contributor.author | Citgez, S. | |
dc.contributor.author | Talat, Z. | |
dc.date.accessioned | 2021-03-02T22:51:14Z | |
dc.date.available | 2021-03-02T22:51:14Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Demirdag C., Citgez S., Talat Z., Onal B., "Management of Bladder Cancer After Renal Transplantation", TRANSPLANTATION PROCEEDINGS, cilt.49, sa.2, ss.293-296, 2017 | |
dc.identifier.issn | 0041-1345 | |
dc.identifier.other | av_0f1a33da-395d-4f69-913b-495fda2d1363 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/15680 | |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2016.11.039 | |
dc.description.abstract | Objectives. In renal transplant recipients, the risk of developing bladder cancer and rate of diagnosis of advanced staged bladder cancer are generally higher than the general population. Also, it is more challenging to treat renal transplant recipients than the regular patient population. We aimed to evaluate the efficacy and safety of radical cystectomy (RC) and urinary diversion with ileal conduit in renal transplant recipients. | |
dc.language.iso | eng | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | TRANSPLANTASYON | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | CERRAHİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.title | Management of Bladder Cancer After Renal Transplantation | |
dc.type | Makale | |
dc.relation.journal | TRANSPLANTATION PROCEEDINGS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 49 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 293 | |
dc.identifier.endpage | 296 | |
dc.contributor.firstauthorID | 59390 | |